New study aims to build mental health support for dads of kids with special needs

NCT ID NCT07591636

Not yet recruiting Knowledge-focused Sponsor: The Hong Kong Polytechnic University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aims to create a therapy program using Acceptance and Commitment Therapy (ACT) for fathers of children with special needs in Hong Kong. Researchers will interview 20 fathers and social workers to understand their challenges and what kind of support would help. The goal is to design a protocol that improves psychological flexibility and mental health for these fathers.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Acceptance and Commitment Therapy (ACT) protocol development via focus groups
What this could lead to: If successful, this could create a tailored therapy program to help fathers of children with special needs cope better with stress and improve their mental health.
What could go wrong: This is a very early, small qualitative study (20 participants) that only develops a protocol, not tests it. The findings may not apply to other cultures or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATTENTION DEFICIT HYPERACTIVITY DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

attention deficit-hyperactivity disorder autism spectrum disorder developmental disability intellectual disability Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CAREGIVER MENTAL HEALTH DEVELOPMENTAL DISABILITIES FATHER PARENTING STRESS SPECIAL NEEDS CHILDREN

More trials for these conditions

Other studies related to the condition(s) this trial covers.